Kerecis

kerecis.com · Reykjavík, Iceland

Kerecis is a medical technology company that develops and manufactures fish-skin–based tissue regeneration and wound care products used to treat chronic wounds, burns, and surgical defects. Its acellular fish-skin grafts are sold to hospitals, clinics, and healthcare providers, primarily in the U.S. and Europe, through a combination of direct sales and distributor channels. The company generates revenue from product sales and related clinical support services in advanced wound care and reconstructive surgery markets.

  • Electronic Health Records
Revenue
$90.0M
Employees
450
Founded
2009
Headquarters
Reykjavík, Iceland

What 12 Arbolus experts think of Kerecis

NPS scores are highly positive, clustering between 7 and 10, with no notable detractors except one. Renewal intent is generally positive, but NotSure responses appear among Influencers. Most users are in the MoreThan1Year implementation stage, indicating stickiness and established usage. Positive sentiment is associated with clinical roles and established users, while Influencers indicate greater uncertainty. Overall Customer Sentiment: Positive

Who reviewed Kerecis

Total customers 12 11 current · 1 former
Reviews growth +9 in six months
Seniority of respondents
  • C-Suite 82% (10)
  • Director 9% (1)
  • Manager 9% (1)
Not specified Director NPS 9 Will renew
Other Generalist C-Suite NPS 8
Product Leader Manager NPS 2 Undecided

Employer names and spend open once the report publishes.

Tell us when the Kerecis report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

8 Net Promoter Score, from 12 scored reviews
  • Promoters 4
  • Passives 5
  • Detractors 3

Cumulative NPS by month

+0 over 6 months
  • Jan 8
  • Feb 6
  • Mar 6
  • Apr 6
  • Jul 7
  • Aug 8

Net Promoter Score across 1 reviews, accumulated up to each month. Category median 8 across 1 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 33%
  • Will renew 1
  • Undecided 2
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 0% 1 answer
  • Director 100% 1 answer
  • Manager 0% 1 answer
  • 9/10 Average score from customers who will renew
  • 4/10 Average score from undecided customers

For people who use Kerecis

Do you use Kerecis at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 12 customers of Kerecis have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.